Jeremy Anderson, PhD, MBA
About Jeremy Anderson, PhD, MBA
Jeremy Anderson, PhD, MBA, serves as the Associate Director of Process Development Analytical Operations and Clinical Quality Control for CAR T Cell Therapy at Kite Pharma. He has extensive experience in quality control and analytical development across various biotechnology companies, including Fate Therapeutics and Novartis Gene Therapies.
Work at Kite Pharma
Jeremy Anderson serves as the Associate Director of Process Development Analytical Operations and Clinical Quality Control (QC) for CAR T Cell Therapy at Kite Pharma. He has been in this role since 2023. In this position, he acts as a subject matter expert for analytical methodologies related to cell therapy testing, which is crucial for the release of clinical drug products. He also leads initiatives aimed at enhancing laboratory efficiencies through Operational Excellence and Lean Six Sigma programs.
Previous Experience in Quality Control
Before joining Kite Pharma, Jeremy held several key positions in quality control across various organizations. He worked at Fate Therapeutics Inc. as Associate Director of Quality Control for iPSC Cell Therapy from 2022 to 2023. Prior to that, he was Site Manager for Commercial Quality Control at Novartis Gene Therapies from 2020 to 2021, and he served as Scientist and Supervisor in the same department from 2019 to 2020. His experience spans multiple aspects of quality control in gene therapy and cell therapy.
Educational Background
Jeremy Anderson has a robust educational background in engineering and business. He earned a Doctor of Philosophy (Ph.D.) in Bioengineering and Biomedical Engineering from Rutgers University. He also holds a Master of Engineering (MEng) from Rutgers University and a Master of Business Administration (MBA) in Innovation and Entrepreneurship from Point Loma Nazarene University. Additionally, he completed his Bachelor of Science (BS) in Bioengineering and Biomedical Engineering at California Lutheran University.
Leadership and Mentorship Roles
In his professional roles, Jeremy has demonstrated leadership and mentorship capabilities. He has overseen teams, including managing the QC Microbiology functional area within the clinical QC department, where he supervised 10 full-time employees. He actively mentors QC personnel to enhance their technical and compliance competencies, supporting their career development. He collaborates with the QC Technical Services group on new product technology transfers and staff training.
Research and Development Experience
Jeremy has extensive experience in research and development, particularly in the field of biologics and gene therapy. He worked as an Associate Scientist in Molecular and Analytical Development at Bristol-Myers Squibb from 2016 to 2019. He also held positions at Ionis Pharmaceuticals as Assistant Director of Analytical Development and Quality Control, and at CURE Pharmaceutical Corp. as a Research Associate. His early research experience includes working as a Graduate Fellow at Rutgers University from 2014 to 2019.